ENW EnWave Corporation

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
announced today that the Company has signed a Commercial Royalty-Bearing License
(the "License") and Machine Purchase Agreement (the "Agreement") with a Canadian
vegetable and herb producer (the "Licensee"). The License grants the Licensee
with the right to dehydrate a number of high-value vegetable and herb products
using EnWave's Radiant Energy Vacuum ("REV(TM)") technology. To enable
commercial production, the Licensee has signed the Agreement to purchase a 20kW
commercial nutraREV(R) unit expected to be delivered to their facilities in the
second half of 2014. 


Prior to signing the License and Agreement, EnWave conducted a series of product
development tests with the Licensee at the Company's pilot plant facilities that
yielded compelling results. Key product characteristics that have become closely
associated with the use of REV(TM) technology, such as high nutritional
retention, strong flavors and natural colors, all contributed to the Licensee's
decision to proceed on a commercial basis. 


"This represents our third commercial licensee in the vegetable market sector,"
stated Dr. Tim Durance, Chairman and Co-CEO of EnWave. "There is increased
momentum building in each of our seven established market sectors and we expect
further market opportunities to be confirmed over the coming quarters."


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV(TM))
dehydration technology. EnWave aims to sign royalty-bearing commercial licenses
with leading food and pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed commercial licenses with Bonduelle,
a global leader in the production of vegetables, for the processing of
dehydrofrozen vegetables; Hormel Food Corporation, a major processed meat
manufacturer, for the production of healthy dried meat products; Milne Fruit
Product, EnWave's first major licensee, for the production of several dehydrated
fruit and vegetable products in the whole, fragmented and powdered form; a
leading North American enzyme company, to dehydrate a series of food-related
enzymes for their Tier 1 clients; and Napa Mountain Spice Company, to dry
high-quality California bay leaves. In addition to these licenses, EnWave has
formed a Limited Liability Partnership with Lucid Capital Management to develop,
manufacture, market and sell all-natural cheese snack products in the United
States under the Moon Cheese(R) brand and NutraDried Creations to market cheese
and other REV(TM) snack products through private label distribution channels in
the United States and Latin America. Most recently, EnWave signed a commercial
royalty-bearing license with NutraDried Creations LLP to enable them to
aggressively market nutritious snack products to private label customers in
North America and Latin America.


Also, EnWave has entered into a wide range of research and collaboration
agreements with an expanding list of multinational companies, including Nestle,
Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Cherry Central,
Sun-Maid Growers, Gay Lea Foods, R.J. Reynolds and Merck. EnWave is introducing
REV(TM) as a new dehydration standard in the food and biological material
sectors: potentially faster and cheaper than freeze drying, with better end
product quality than air drying or spray drying.


EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(R) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net. 


EnWave Corporation 

Dr. Tim Durance, Chairman & Co-CEO 

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures, and the
expected synergies following the closing are forward-looking statements. All
third party references to market information in this release are not guaranteed
to be accurate as the Company did not conduct the original primary research.
These statements are not a guarantee of future performance and involve a number
of risks, uncertainties and assumptions. Although the Company has attempted to
identify important factors that could cause actual results to differ materially,
there may be other factors that cause results not to be as anticipated,
estimated or intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place
undue reliance on forward-looking statements.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
EnWave Corporation
Mr. John McNicol
President & Co-CEO
(604) 601-8524
john.mcnicol@enwave.net


EnWave Corporation
Mr. Brent Charleton
Vice President, Corporate Affairs
(778) 378-9616
bcharleton@enwave.net
www.enwave.net

EnWave (TSXV:ENW)
Historical Stock Chart
From Apr 2024 to May 2024

EnWave (TSXV:ENW)
Historical Stock Chart
From May 2023 to May 2024